Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, pleas
Ja – Apellis Pharmaceuticals hat aktuell 15 offene Stellen auf JobsRadar, verteilt auf 3 Abteilungen und 5 Standorte. 2 davon wurden in den letzten 30 Tagen ausgeschrieben. Davon machen 11 Angaben zum Gehalt – im Median $169,000 pro Jahr. Zuletzt aktualisiert am 28. Oktober 2026 um 06:07 UTC.